FLAGSTAFF, Ariz.--(BUSINESS WIRE)--W. L. Gore & Associates, Inc. (Gore) announces the FDA approval and U.S. launch of the GORE® VIATORR® TIPS Endoprosthesis with Controlled Expansion for Transjugular ...
The progressive worsening of liver cirrhosis and portal hypertension (HTN) decreases intra-hepatic nitric oxide (NO), which is counterbalanced by increased NO secretion from adjacent endothelial cells ...
Cirrhosis is one of the leading causes of mortality from non-communicable diseases, with complications arising as liver function deteriorates. HRS and HPS represent the most severe outcomes of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback